recognized to be most commonly related to lymphoproliferative neoplasms, such as non-Hodgkin's lymphoma (42%), chronic lymphocytic leukemia (29%), and Castleman's disease (CD, 10%). 2 These tumors elicited autoantibodies against various antigens from the plakin family expressed in keratinocytes, particularly envoplakin (210 kD) and periplakin (190 kD).
Unlike in adults, PNP in pediatric patients was most commonly caused by CD rather than non-Hodgkin's lymphoma. 3 Due to its rareness, PNP initially is difficult to identify. The oral ulcers, blisters, or skin eruptions might be clinically indistinguishable from herpes simplex virus infection, Steven-Johnson syndrome, or autoimmune diseases such as systemic lupus erythematosus, Behçet's disease, or another pemphigus. Here, we report a case of severe aphthous stomatitis and lichen planus with concurrent unicentric CD resulting in bronchiolitis obliterans (BO). In addition, we analyzed the reported pediatric patients in terms of their clinical and pathological manifestations, management, and outcome to determine the characteristic(s) that facilitate the earlier diagnosis and more effective therapy of PNP resulting from CD in children.
| ME THODS
The aim of the study is to describe the features of PNP resulting from CD and to find clues for the early diagnosis in pediatric patients. We report an index case and perform a literature review of PNP and CD in children between 1997 and 2016. The clinical manifestations, pathological findings, treatment, and outcome are analyzed.
| The index case
A 13-year-old girl presented with a 6-month history of recurrent painful oral ulcers and a 2-month history of multiple violaceous lichen planus on the face, scalp, and both hands ( Figure 1 ). She denied having fever, malaise, night sweats, body weight loss, hair loss, malar rash, photosensitivity, joint pain, common cold, gastrointestinal discomfort, abnormal urine appearance, or genital ulcers. She was healthy until the onset of the mucocutaneous lesions. She had no family history of autoimmune or autoinflammatory disease. She exhibited dyspnea on exertion and an audible wheeze 2 weeks later. Her chest X-ray showed hyperinflation in both lungs ( Figure 2D ). Her pulmonary function test yielded severe obstructive lung disease with a low vital capacity. Chest computed tomography (CT) revealed slightly diffuse bronchial wall thickening and mosaic patterns in bilateral lungs without significant mediastinum lymphadenopathy ( Figure 3A) . A hypervascular heterogeneous tumor F I G U R E 2 Histological, immunofluorescence, and radiographic images of the index case. A, skin: keratinocytes necrosis (white arrowhead), vacuolar interface change (black arrowhead) (hematoxylin and eosin, original magnification ×200). B, oral mucosa: acantholysis (arrow) (hematoxylin and eosin, original magnification ×200). C, anti-intercellular substance antibody titer 1:80 in the indirect immunofluorescence stain (original magnification ×400). D, hyperinflation on chest X-ray 
| Literature review
We searched the MEDLINE and PubMed databases by using the keywords "Paraneoplastic pemphigus" and "Castleman's disease".
The inclusion criteria were articles published in English for the period from 1997 to 2016 and those examining individuals aged less than 18 years. The exclusion criteria were articles without full text or detailed descriptions of the patient's condition. A total of 11 case reports and 6 original articles were selected. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] The original articles were mainly conducted at 2 medical centers, that is, 2 at the
Department of Dermatology of Johns Hopkins University and 4 at
Peking University First Hospital. We cross-matched the patients' data and excluded those patients with repeated calculations. One patient included in one of the aforementioned articles was also described in a case report published in 1986. 15, 18 Thus, more details of this patient could be searched.
| Data collection
A total of 32 cases, including our index case, were identified and reviewed. We collected data on their: age; sex; clinical manifestations of mucocutaneous lesions; pulmonary condition; image findings; types of CD; histopathological findings for skin, mucosa, lung, and tumor; direct immunofluorescence and indirect immunofluorescence; treatment; survival time; and outcome. Although the classifications of histological findings for CD were not mentioned for 3 patients, 19 we surmised them to be the HV variant according to the descriptions because of the statement of marked enhancement in CT images in the article. 20 
| RE SULTS

| Patient demography
Overall, 32 cases were included in this study (16 male and 16 female patients). Patient information is summarized in Tables 1 and 2 . The mean age was 14.0 ± 2.6 years. The disease most often occurred at the age of 16 years.
| Clinical manifestations
A review of the case reports revealed that the initial manifestations were mucocutaneous lesions with a poor response to conventional treatment, and CD was incidentally discovered later during the survey for pemphigus. The most frequent mucocutaneous problem was recurrent intractable severe painful stomatitis. All included patients skin manifestations, the lichenoid feature was the most frequently observed (38.5%, 10 of 26).
| Histological and immunofluorescence findings for PNP
In our study, 25 of 32 patients had well-recorded pathology findings ( 
| Histological findings for CD
After the 12 patients with incomplete description of the underlying CD were excluded, the tumor in the remaining 20 patients was found to 
| Treatment
For CD, almost all patients underwent surgical resection of the tumor, except one patient who did not undergo an operation, 3,14 and one (case No. 9) who underwent partial resection of the tumor.
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For PNP, the patients with clear medication recording all received corticosteroids; however, the response was unsatisfactory.
The mucocutaneous erosion gradually resolved after tumor removal.
However, pulmonary involvement persisted. Other drugs like azathioprine, methotrexate, cyclosporine, cyclophosphamide, IVIG and target therapy medications such as rituximab and tocilizumab were also used for treating the severe mucocutaneous erosion and for the Two patients finally received lung transplantation, and they both survived.
3,11,14
| Prognosis
The outcome was recorded in 30 patients. Overall, 9 patients survived, and 21 patients finally died in 2 weeks to 2 years after the diagnosis.
Respiratory failure was the major cause of death (81.0%, 17 of 21 deaths).
Among the 9 children who survived, pulmonary involvement was found in 6 patients (66.7%), and 2 of them received lung transplantations. 3, 11, 14 The longest survival time was more than 3 years in 1 patient. 17, 19 In the mortality group, 19 patients (90.5%) exhibited pulmonary involvement, whereas 2 (9.5%) patients did not. A total of 17 patients died of respiratory failure, and one patient died of severe infection after an operation. 19 The causes of death of the remaining three patients were not mentioned.
3,14
The mortality rate in the patients with and without pulmonary involvement was 76% (19 of 25) and 40% (2 of 5), respectively (P = .1432).
| D ISCUSS I ON
PNP in pediatric patients is most often concurrent with CD. 3 To date, few studies have focused on PNP and CD in the pediatric population.
In our study, the disease developed more often in adolescents, with equal predominance in both sexes. All patients initially presented with aphthous stomatitis, along with other mucocutaneous erosions, which was unresponsive to conventional therapies and appeared much earlier than the diagnosis of the tumor. The delay in diagnosis was due to the asymptomatic tumor and workup that deviated the diagnosis to other autoimmune diseases.
Although CD is a rare and benign lymphoproliferative disease, 21 it may cause complications such as PNP. In a single-center Humoral immunity is induced by the production of autoantibodies against the plakin family, including periplakin, envoplakin, desmoplakin, plectin, and bullous pemphigoid antigen 1. 25 The mechanism of paraneoplastic-associated immune dysfunction includes epitope spreading, antigen mimicry, cytotoxicity, autoantibody formation, and interleukin-6. 25 The spectrum of the clinical mucocutaneous manifestations ranges from bullous pemphigoid-like lesions to erythema multiforme-like, graft-versus-host disease-like, and lichen planus-like lesions. 25 Given the realization of the spectrum of cutaneous manifestations, it is worth performing tissue biopsy to clarify the exact cause of skin changes. We suggest that workup for change. 12, [27] [28] [29] In a previous study in China, BO was reported in 10 of 37 patients with PNP and CD (27%). 21 Nevertheless, in our study, the pulmonary involvement rate was as high as 81.2% (26 of 32). Among the 25 children with pulmonary involvement and well-recorded outcomes, 17 patients (68%) died of respiratory failure. In the pediatric patients with PNP resulting from CD, BO may be more prevalent and may be the leading cause of mortality. Myasthenia gravis was reported in the adults with PNP resulting from CD 22 ; however, no report in the pediatric population is available.
In the reported pediatric patients, mucocutaneous lesions improved after total removal of the Castleman's tumor. 7,9,11-13 BO was The prevention strategies for BO should be investigated in additional studies; at least, the strategies for earlier diagnosis of PNP and CD must be established in the future.
| CON CLUS ION
Because intractable mucocutaneous lesions in children may be the first sign of PNP resulting from CD, biopsy and early detection of the underlying tumor are crucial. Pulmonary involvement is the key aspect that determines a patient's outcome. Earlier diagnosis is mandatory for a more effective management of PNP resulting from CD and pulmonary involvement.
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